1152617-29-2 Usage
Description
Imidazo[1,2-a]pyridine-8-carbonitrile, 7-hydroxy-, also known as 7-hydroxyimidazo[1,2-a]pyridine-8-carbonitrile, is a chemical compound characterized by a heterocyclic structure that includes both an imidazole and a pyridine ring. Imidazo[1,2-a]pyridine-8-carbonitrile, 7-hydroxyfeatures a hydroxy group at the 7th position of the imidazole ring, which contributes to its unique structural and pharmacological properties. It is utilized in pharmaceutical research and development, particularly for the synthesis of potential drug candidates, and may hold therapeutic potential for various diseases.
Uses
Used in Pharmaceutical Research and Development:
Imidazo[1,2-a]pyridine-8-carbonitrile, 7-hydroxyis employed as a key intermediate in the synthesis of potential drug candidates due to its unique structural and pharmacological properties. Its presence in these compounds may contribute to their therapeutic potential in treating various diseases.
Used as a Building Block in Organic Synthesis:
In the field of organic chemistry, Imidazo[1,2-a]pyridine-8-carbonitrile, 7-hydroxyserves as a valuable building block for the synthesis of more complex organic compounds. Its heterocyclic structure and functional groups make it a versatile component in the creation of novel molecules with diverse applications.
Check Digit Verification of cas no
The CAS Registry Mumber 1152617-29-2 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,1,5,2,6,1 and 7 respectively; the second part has 2 digits, 2 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 1152617-29:
(9*1)+(8*1)+(7*5)+(6*2)+(5*6)+(4*1)+(3*7)+(2*2)+(1*9)=132
132 % 10 = 2
So 1152617-29-2 is a valid CAS Registry Number.
InChI:InChI=1S/C8H5N3O/c9-5-6-7(12)1-3-11-4-2-10-8(6)11/h1-4,12H
1152617-29-2Relevant articles and documents
IMIDAZO[1,2-A]PYRIDINE DERIVATIVES AND THEIR USE AS POSITIVE ALLOSTERIC MODULATORS OF MGLUR2 RECEPTORS
-
Page/Page column 55, (2009/06/27)
The present invention relates to novel compounds, in particular novel imidazo[1,2-a]piridine derivatives according to Formula (I) wherein all radicals are as defined in the application and claims. The compounds according to the invention are positive allosteric modulators of metabotropic receptors - subtype 2 ("mGluR2") which are useful for the treatment or prevention of neurological and psychiatric disorders associated with glutamate dysfunction and diseases in which the mGluR2 subtype of metabotropic receptors is involved. In particular, such diseases are central nervous system disorders selected from the group of anxiety, schizophrenia, migraine, depression, and epilepsy. The invention is also directed to pharmaceutical compositions and processes to prepare such compounds and compositions, as well as to the use of such compounds for the prevention and treatment of such diseases in which mGluR2 is involved.
